Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 11, 2015, Pages 2005-2014.e3

  Ho, Samuel B ^a,b   Bräu, Norbert ^e   Cheung, Ramsey ^f,g   Liu, Lin ^c   Sanchez, Courtney ^a   Sklar, Marisa ^a   Phelps, Tyler E ^f   Marcus, Sonja G ⁱ   Wasil, Michelene M ^a   Tisi, Amelia ⁱ   Huynh, Lia ^g   Robinson, Shannon K ^a,d   Gifford, Allen L ^e,j   Asch, Steven M ^g,h   Groessl, Erik J ^a,c  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j BOSTON UNIVERSITY   (United States)

more..

Author keywords

Care Integration; Hepatitis C; PTSD; Substance Use Disorders

Indexed keywords

PEGINTERFERON ALPHA; RIBAVIRIN;

ADULT; ALCOHOL ABUSE; ANTIVIRAL THERAPY; ARTICLE; CASE MANAGEMENT; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HIGH RISK POPULATION; HOMELESSNESS; HUMAN; INTEGRATED CARE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICATION COMPLIANCE; MENTAL DISEASE; MENTAL HEALTH CARE; MIDDLE AGED; MULTICENTER STUDY; MULTIDISCIPLINARY CARE COORDINATION; OUTCOME ASSESSMENT; PATIENT CARE; POSTTRAUMATIC STRESS DISORDER; PROSPECTIVE STUDY; PROTOCOL COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; SUSTAINED VIROLOGIC RESPONSE; TIME TO TREATMENT; UNITED STATES; VIRAL PHENOMENA AND FUNCTIONS; AGED; COMPLICATION; HEPATITIS C, CHRONIC; INTEGRATED HEALTH CARE SYSTEM; MENTAL DISORDERS; ORGANIZATION AND MANAGEMENT; PROCEDURES; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

ADULT; AGED; CASE MANAGEMENT; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNITED STATES;

EID: 84944279905     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.02.022     Document Type: Article

References (42)

1. Backus L.I., Belperio P.S., Loomis T.P., et al. Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs care. JAMA Intern Med 2013, 173:1549-1552.
2. Veldt B.J., Heathcote E.J., Wedemeyer H., et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med 2007, 147:677-684.
3. Morgan T.R., Ghany M.G., Kim H.Y., et al. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology 2010, 52:833-844.
4. Dieperink E., Pocha C., Thuras P., et al. All-cause mortality and liver-related outcomes following successful antiviral treatment for chronic hepatitis C. Dig Dis Sci 2014, 59:872-880.
5. Liu S., Cipriano L.E., Holodniy M., et al. New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis. Ann Intern Med 2012, 156:279-290.
6. Camma C., Petta S., Cabibbo G., et al. Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C. J Hepatol 2013, 59:658-666.
7. Chan K., Lai M.N., Groessl E.J., et al. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration. Clin Gastroenterol Hepatol 2013, 11:1503-1510.
8. Veterans Affairs. State of care for veterans with hepatitis C. US Department of Veterans Affairs, Public Health Strategic Healthcare Group, Center for Quality Management in Public Health, 2010. updated Nov 2014. Available: Accessed November 2014. http://www.hepatitis.va.gov/index.asp.
9. Holmberg S.D., Spradling P.R., Moorman A.C., et al. Hepatitis C in the United States. N Engl J Med 2013, 368:1859-1861.
10. Davis G.L., Alter M.J., El-Serag H., et al. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010, 138:513-521.
11. Ho S.B., Groessl E., Dollarhide A., et al. Management of chronic hepatitis C in veterans: the potential of integrated care models. Am J Gastroenterol 2008, 103:1810-1823.
12. North C.S., Hong B.A., Adewuyi S.A., et al. Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations. Gen Hosp Psychiatry 2013, 35:122-128.
13. Judd S., Liubakka A.M., Payle A., et al. Assessing key barriers to treatment of chronic hepatitis C virus (HCV) with next generation agents in a veteran population. Gastroenterology 2014, 146:S-737.
14. Medicaid restricts eligibility for new HCV treatments, 2014.Available at; Accessed November 2014. http://www.governing.com/topics/health-human-services/gov-hepatitis-coverage-solvaldi-lawsuits.html.
15. Willenbring M.L. Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches. AIDS 2005, 19(Suppl 3):S227-S237.
16. Gardner L.I., Metsch L.R., Anderson-Mahoney P., et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS 2005, 19:423-431.
17. Bruggmann P., Litwin A.H. Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all. Clin Infect Dis 2013, 57(Suppl 2):S56-S61.
18. Groessl E.J., Sklar M., Cheung R.C., et al. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial. Contemp Clin Trials 2013, 35:97-107.
19. Yee H.S., Currie S.L., Darling J.M., et al. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office. Am J Gastroenterol 2006, 101:2360-2378.
20. Martinot-Peignoux M., Stern C., Maylin S., et al. Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin. Hepatology 2010, 51:1122-1126.
21. Lawitz E., Mangia A., Wyles D., et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med 2013, 368:1878-1887.
22. El-Serag H.B., Kunik M., Richardson P., et al. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 2002, 123:476-482.
23. Soto T.A., Bell J., Pillen M.B. Literature on integrated HIV care: a review. AIDS Care 2004, 16(Suppl 1):S43-S55.
24. Woltmann E., Grogan-Kaylor A., Perron B., et al. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. Am J Psychiatry 2012, 169:790-804.
25. Knott A., Dieperink E., Willenbring M.L., et al. Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. Am J Gastroenterol 2006, 101:2254-2262.
26. Schaefer M., Hinzpeter A., Mohmand A., et al. Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. Hepatology 2007, 46:991-998.
27. Sylvestre D.L., Clements B.J. Adherence to hepatitis C treatment in recovering heroin users maintained on methadone. Eur J Gastroenterol Hepatol 2007, 19:741-747.
28. Brunner N., Senn O., Rosemann T., et al. Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre: a retrospective analysis. Eur J Gastroenterol Hepatol 2013, 25:1300-1307.
29. Evon D.M., Simpson K., Kixmiller S., et al. A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment. Am J Gastroenterol 2011, 106:1777-1786.
30. Linas B.P., Barter D.M., Leff J.A., et al. The hepatitis C cascade of care: identifying priorities to improve clinical outcomes. PLoS One 2014, 9:e97317.
31. Groessl E.J., Sklar M., Cheung R.C., et al. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial. Contemp Clin Trials 2013, 35:97-107.
32. Beck A.T., Rush A.J., Shaw B.F., et al. Cognitive therapy of depression 1979, Guilford Press, New York.
33. Beck A.T., Steer R.A., Ball R., et al. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996, 67:588-597.
34. Williams J.R., Hirsch E.S., Anderson K., et al. A comparison of nine scales to detect depression in Parkinson disease: which scale to use?. Neurology 2012, 78:998-1006.
35. Wang Y.P., Gorenstein C. Assessment of depression in medical patients: a systematic review of the utility of the Beck Depression Inventory-II. Clinics Sao Paolo 2013, 68:1274-1287.
36. Ouimette P., Wade M., Prins A., et al. Identifying PTSD in primary care: comparison of the Primary Care-PTSD screen (PC-PTSD) and the General Health Questionnaire-12 (GHQ). J Anxiety Disord 2008, 22:337-343.
37. Bush K., Kivlahan D.R., McDonell M.B., et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998, 158:1789-1795.
38. Knott A., Dieperink E., Willenbring M.L., et al. Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. Am J Gastroenterol 2006, 101:2254-2262.
39. Yee H.S., Currie S.L., Darling J.M., et al. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office. Am J Gastroenterol 2006, 101:2360-2378.
40. Hosmer D.W., Lemeshow S. Applied logistic regression 2000, Wiley, New York.
41. Hosmer D.W., Lemeshow S., May S. Applied survival analysis: regression modeling of time-to-event data 2008, Wiley-Interscience, Hoboken, NJ. 2nd ed.
42. Grambsch P.M., Therneau T.M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994, 81:515-526.